Medical School, Hunan University of Chinese Medicine, Hanpu Science and Education Industrial Park, Changsha City, China.
School of Integrated Chinese and Western Medicine, Hunan University of Chinese Medicine, Hanpu Science and Education Industrial Park, Changsha City, China.
Medicine (Baltimore). 2024 Oct 4;103(40):e39793. doi: 10.1097/MD.0000000000039793.
Traditional Chinese medicine (TCM) demonstrates significant effects on renal function, yet it remains unclear which TCM treatment yields the best clinical outcomes for renal hypertension (RH) management. This study aims to evaluate the safety and effectiveness of various TCM treatments for RH compared to conventional Western medicine (CWM).
Randomized controlled trials (RCTs) of TCM for RH were screened from 9 databases, covering the period up to July 2023. The Cochrane Risk of Bias tool was utilized to assess the risk of bias in the included RCTs. Network meta-analysis was conducted using RevMan 5.3 and Stata 14.0 software. Sensitivity analyses and meta-regression were performed to identify sources of heterogeneity and assess result robustness.
This study encompassed 3879 patients from 44 investigations involving 29 TCM interventions. The quality of the studies ranged from moderate to excellent, with well-defined inclusion criteria and generally low potential for biases related to outcome data and selective reporting. Tianma Gouteng Yin combined with Qiju Dihuang Wan + CWM demonstrated the highest total effective rate (relative risk = 1.31, 95% confidence interval (CI): 1.03, 1.66) compared to CWM alone. Bailing capsule + CWM was optimal for improving serum creatinine (mean difference (MD) = -53.78, 95% CI: -96.59, -10.98). Ziyin Pinggan Huayu decoction + CWM had the highest likelihood (surface under the cumulative ranking curves = 56.2%) of improving blood urea nitrogen. Zishen Pinggan prescription + CWM showed the greatest improvement in systolic blood pressure (MD = -46.29, 95% CI: -73.19, -19.38), while Ye Ren Gao decoction + CWM demonstrated the best improvement in diastolic blood pressure (MD = -13.13, 95% CI: -20.12, -6.13). Xifeng Qingnao decoction + CWM achieved the best improvement in 24-hour urinary protein (MD = -2.00, 95% CI: -3.26, -0.74). The combination of TCM and CWM was associated with a lower incidence of adverse effects.
Combination therapy of TCM with CWM surpasses CWM alone in treating renal hypertension. This study identifies the most effective combination treatment for RH, as well as optimal treatments for lowering blood pressure (Zishen Pinggan prescription + CWM) and improving renal function (Bailing capsule + CWM).
中医在肾功能方面表现出显著的效果,但对于肾性高血压(RH)管理,哪种中医治疗能取得最佳的临床效果仍不清楚。本研究旨在评估与传统西医(CWM)相比,各种中医治疗 RH 的安全性和有效性。
从 9 个数据库中筛选出关于中医治疗 RH 的随机对照试验(RCT),时间截至 2023 年 7 月。使用 Cochrane 偏倚风险工具评估纳入 RCT 的偏倚风险。使用 RevMan 5.3 和 Stata 14.0 软件进行网络荟萃分析。进行敏感性分析和 meta 回归,以确定异质性的来源并评估结果的稳健性。
本研究共纳入了来自 44 项研究的 3879 例患者,共涉及 29 种中医干预措施。研究的质量从中等到良好不等,纳入标准定义明确,并且与结局数据和选择性报告相关的偏倚风险通常较低。天麻钩藤饮联合杞菊地黄丸+ CWM 与单独使用 CWM 相比,总有效率最高(相对风险=1.31,95%置信区间(CI):1.03,1.66)。百灵胶囊+ CWM 最适合改善血清肌酐(均数差(MD)=-53.78,95%CI:-96.59,-10.98)。滋阴平肝化瘀汤+ CWM 最有可能改善血尿素氮(累积排序曲线下面积(SUCRA)=56.2%)。自拟滋阴平肝方+ CWM 显示收缩压的最大改善(MD=-46.29,95%CI:-73.19,-19.38),而益肾膏方+ CWM 显示舒张压的最佳改善(MD=-13.13,95%CI:-20.12,-6.13)。息风清肝汤+ CWM 实现了 24 小时尿蛋白的最佳改善(MD=-2.00,95%CI:-3.26,-0.74)。中医与 CWM 的联合治疗与单独使用 CWM 相比,不良反应发生率更低。
与单独使用 CWM 相比,中医与 CWM 的联合治疗在治疗肾性高血压方面更具优势。本研究确定了治疗 RH 最有效的联合治疗方法,以及降低血压(自拟滋阴平肝方+ CWM)和改善肾功能(百灵胶囊+ CWM)的最佳治疗方法。